- American Academy of Pediatrics
- American Thoracic Society
Lael Yonker, M.D.
Chief, Division of Pediatric Pulmonology and Sleep Medicine
- Pogue Distinguished Chair in Pediatric Pulmonology Medicine
- Pediatrics - Pulmonology and Sleep Medicine
- Pediatric Pulmonary Disease
- Post-Infectious Syndromes, Including MIS-C and Long COVID
Biography
Lael Yonker, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She serves as Chief of its Division of Pulmonology and Sleep Medicine and Medical Director of the Children’s Pulmonary Translational Research Center. Dr. Yonker also holds the Pogue Distinguished Chair in Pediatric Pulmonology Medicine. She specializes in pediatric pulmonary disease and cystic fibrosis.
Dr. Yonker earned her medical degree at the University of Massachusetts. She completed a residency in pediatrics and received advanced training through a pediatric pulmonary fellowship, both at Mass General Brigham.
Certified by the American Board of Pediatrics, she joined the UT Southwestern faculty in 2025. She previously was a faculty member at Mass General Brigham, where she was director of the Cystic Fibrosis Center, co-director of the Cystic Fibrosis Therapeutic Development Center, co-director of the Pulmonary Genetics Program, and principal investigator for the Pediatric COVID-19 Biorepository.
As a physician-scientist, Dr. Yonker integrates clinical pulmonary care with translational research to improve outcomes for children with complex respiratory disease. Her work bridges mechanistic studies in patient‑derived samples with hypothesis‑driven clinical trials to identify and interrupt maladaptive inflammatory pathways. The goal of her scientific program is to define infection-driven mechanisms that lead to airway and systemic disease in children and leverage these insights to develop targeted therapies.
Dr. Yonker contributes to national and international medical leadership through service with the Cystic Fibrosis Foundation and the American Thoracic Society. She has contributed foundational insights into post–COVID‑19 inflammatory syndromes, co‑invented a diagnostic method for a monocytic biomarker used to identify COVID‑19-related illness, and patented therapeutic strategies for multisystem inflammatory syndrome in children.
In 2024, she earned the Emerging Leader Award from the National Academy of Medicine.
Personal Note
When she’s not at work, Dr. Yonker enjoys spending time with family, cheering on her children at their sports events, exploring the outdoors, watching hockey, and trying new restaurants.
Professional Associations & Affiliations
Honors & Awards
- Pillars of Excellence Award 2022, Massachusetts General Hospital
- Robert B. Mellins, M.D. Outstanding Achievement Award 2023, American Thoracic Society
- Journeys & Frontiers in Pediatric Research Nominated Participant 2023-2024, American Pediatric Society and Society of Pediatric Research
- Emerging Leader Award 2024, National Academy of Medicine
- Early Career Investigator Excellence Award 2024, Mass General Brigham for Children
- Pogue Distinguished Chair in Pediatric Pulmonology Medicine 2025, UT Southwestern Medical Center
Books & Publications
-
Books
-
Pediatric COVID-19 in The COVID-19 Textbook: Science, Medicine and Public Health
Martens A, Yonker LM (2024), Wolters Kluwer -
Genetic Pediatric Pulmonary Disease in Imaging in Pediatric Pulmonology (2nd ed.)
Hawley MH, Moschovis PP, Kinane TB, Yonker LM (2020), Cham, Switzerland, Springer Nature -
What might be the future of CF prevention and treatment? in Facing Cystic Fibrosis: A Guide for Patients and Their Families
Yonker LM (2020), MGH Psychiatry Academy -
Pediatric Pulmonology in Pocket Pediatrics (2nd ed.)
Canton H, Labowsky AT, Tse SM, Yonker LM, Noviski N (2013), Philadelphia, Lippincott, Williams, and Wilkins -
Flexible Bronchoscopy in Advances in Oto-Rhino-Laryngology
Yonker LM, Fracchia MS (2012), Basel (Switzerland), Karger -
Pediatric Pulmonology in Pocket Pediatrics
Moschovis PP, Yonker LM, Parsons EC, Nelson BA, Sadot E, Scirica CV, Haver K, Noviski N (2009), Philadelphia, Lippincott, Williams, and Wilkins
-
Pediatric COVID-19 in The COVID-19 Textbook: Science, Medicine and Public Health
-
Publications
-
Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.
Yonker LM, Kane AS, Swank Z, Papadakis L, Kenyon V, Han S, Lima R, Guthrie LB, Alvarez-Carcamo B, Lahoud-Rahme M, Balaguru D, Carroll RW, Lok J, El Saleeby C, Walt DR, Fasano A, Science translational medicine 2025 Jul 17 809 eadu4284 -
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A, The Lancet. Respiratory medicine 2025 Mar 13 3 256-271 -
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, Deeks SG, Eimer W, Ely EW, Fasano A, Freire M, Geng LN, Griffin DE, Henrich TJ, Iwasaki A, Izquierdo-Garcia D, Locci M, Mehandru S, Painter MM, Peluso MJ, Pretorius E, Price DA, Putrino D, Scheuermann RH, Tan GS, Tanzi RE, VanBrocklin HF, Yonker LM, Wherry EJ, Nature immunology 2023 Oct 24 10 1616-1627 -
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.
Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, Davis JP, Loiselle M, Novak T, Senussi Y, Cheng CA, Burgess E, Edlow AG, Chou J, Dionne A, Balaguru D, Lahoud-Rahme M, Arditi M, Julg B, Randolph AG, Alter G, Fasano A, Walt DR, Circulation 2023 Mar 147 11 867-876 -
Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children.
Boribong BP, LaSalle TJ, Bartsch YC, Ellett F, Loiselle ME, Davis JP, Gonye ALK, Sykes DB, Hajizadeh S, Kreuzer J, Pillai S, Haas W, Edlow AG, Fasano A, Alter G, Irimia D, Sade-Feldman M, Yonker LM, Cell reports. Medicine 2022 Dec 3 12 100848 -
Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
Shook LL, Atyeo CG, Yonker LM, Fasano A, Gray KJ, Alter G, Edlow AG, JAMA 2022 Mar 327 11 1087-1089 -
Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP, Bartsch YC, Loiselle M, Rivas MN, Porritt RA, Lima R, Davis JP, Farkas EJ, Burns MD, Young N, Mahajan VS, Hajizadeh S, Lopez XIH, Kreuzer J, Morris R, Martinez EE, Han I, Griswold K, Barry NC, Thompson DB, Church G, Edlow AG, Haas W, Pillai S, Arditi M, Alter G, Walt DR, Fasano A, The Journal of clinical investigation 2021 Jul 131 14 -
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses.
Yonker LM, Neilan AM, Bartsch Y, Patel AB, Regan J, Arya P, Gootkind E, Park G, Hardcastle M, St John A, Appleman L, Chiu ML, Fialkowski A, De la Flor D, Lima R, Bordt EA, Yockey LJ, D'Avino P, Fischinger S, Shui JE, Lerou PH, Bonventre JV, Yu XG, Ryan ET, Bassett IV, Irimia D, Edlow AG, Alter G, Li JZ, Fasano A, The Journal of pediatrics 2020 Dec 227 45-52.e5 -
Recognizing genetic disease: A key aspect of pediatric pulmonary care.
Yonker LM, Hawley MH, Moschovis PP, Lu M, Kinane TB, Pediatric pulmonology 2020 Jul 55 7 1794-1809
-
Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.
Research
- Translational research in pediatric respiratory infections, including COVID-19, RSV, and Pseudomonas aeruginosa
- Cystic fibrosis
- Airway inflammation
Clinical Focus
- Pediatric Pulmonary Disease
- Post-Infectious Syndromes, Including MIS-C and Long COVID
- Cystic Fibrosis
Results: 1 Locations
Children's Medical Center of Dallas
1935 Medical District DriveDallas, Texas 75235 214-730-5437 Directions to Children's Medical Center of Dallas at Children's Medical Center of Dallas, Dallas